| Index | — | P/E | 15.00 | EPS (ttm) | 0.63 | Insider Own | 1.97% | Shs Outstand | 558.41M | Perf Week | 2.49% |
| Market Cap | 5.28B | Forward P/E | 4.00 | EPS next Y | 2.37 | Insider Trans | -0.87% | Shs Float | 555.91M | Perf Month | 8.50% |
| Enterprise Value | 45.07B | PEG | 5.15 | EPS next Q | 0.68 | Short Float | 5.91% | Perf Quarter | -7.80% | ||
| Income | 503.00M | P/S | 0.87 | EPS this Y | 7.26% | Short Ratio | 5.56 | Perf Half Y | -1.97% | ||
| Sales | 6.08B | P/B | 0.55 | EPS next Y | 1.41% | ROA | 0.89% | Short Interest | 32.85M | Perf YTD | -13.30% |
| Book/sh | 17.08 | P/C | 2.15 | EPS next 5Y | 2.91% | ROE | 5.90% | 52W High | 12.15 -22.22% | Perf Year | -14.01% |
| Cash/sh | 4.39 | P/FCF | 16.97 | EPS past 3/5Y | -16.71% — | ROIC | 39.27% | 52W Low | 8.31 13.72% | Perf 3Y | 2.83% |
| Dividend Est. | 1.00 (10.58%) | EV/EBITDA | 21.49 | Sales past 3/5Y | 50.47% 31.34% | Gross Margin | 82.81% | Volatility | 2.02% 2.69% | Perf 5Y | -18.60% |
| Dividend TTM | 1.00 (10.58%) | EV/Sales | 7.41 | EPS Y/Y TTM | -56.52% | Oper. Margin | 28.88% | ATR (14) | 0.26 | Perf 10Y | -31.82% |
| Dividend Ex-Date | Oct 01, 2026 | Quick Ratio | 0.13 | Sales Y/Y TTM | 22.11% | Profit Margin | 8.29% | RSI (14) | 59.32 | Recom | 2.05 |
| Dividend Gr. 3/5Y | 0.00% 14.87% | Current Ratio | 0.13 | EPS Q/Q | 1.85% | SMA20 | 6.82% | Beta | 1.16 | Target Price | 13.50 |
| Payout | 101.84% | Debt/Eq | 4.43 | Sales Q/Q | 31.63% | SMA50 | 1.69% | Rel Volume | 1.48 | Prev Close | 9.31 |
| Employees | 7,240 | LT Debt/Eq | 2.46 | Earnings | Feb 02 | SMA200 | -2.55% | Avg Volume | 6.01M | Price | 9.45 |
| IPO Date | May 02, 2013 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 10.22% 19.65% | Net Debt/EBITDA | 18.98 | Volume | 8,867,446 | Change | 1.50% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-21-26 | Reiterated | UBS | Buy | $15 → $14 |
| Jun-16-26 | Reiterated | BTIG | Buy | $16 → $13 |
| May-01-26 | Reiterated | Wedbush | Outperform | $14 → $13 |
| Apr-10-26 | Reiterated | UBS | Buy | $15 |
| Apr-09-26 | Initiated | Lucid Capital | Buy | $13 |
| Feb-06-26 | Reiterated | UBS | Buy | $16 → $15 |
| Feb-04-26 | Reiterated | Piper Sandler | Overweight | $16 → $15 |
| Jan-08-26 | Resumed | UBS | Buy | $13 → $16 |
| Dec-22-25 | Reiterated | Piper Sandler | Overweight | $14 → $16 |
| Dec-15-25 | Reiterated | Wedbush | Outperform | $14 |
Rithm Capital Corp. operates as an asset manager focused on real estate, credit, and financial services in the United States. It operates through Origination and Servicing, Residential Transitional Lending, and Asset Management and Investment Portfolio. The company’s investment portfolio primarily comprises of single-family rental properties, title, appraisal and property preservation and maintenance businesses; real estate securities, call rights, SFR properties, residential mortgage loans, collateralized loan obligations and consumer loans, excess mortgage servicing rights, servicer advance investments, and asset management related investments. It also provides government-sponsored enterprise (GSE) and government guaranteed loans; non-GSE or non-government guaranteed loans; and residential transitional lending. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as New Residential Investment Corp. and changed its name to Rithm Capital Corp. in August 2022. Rithm Capital Corp. was incorporated in 2011 and is based in New York, New York.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 6,081 | 5,686 | 4,739 | 3,757 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,046 | 541 | 265 | 176 | — | — | — | — | — | |
| Gross Profit | 5,037 | 5,145 | 4,473 | 3,581 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 1,757 | 0 | 1,409 | 1,022 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 1,523 | 2,611 | -31 | 404 | — | — | — | — | — | |
| Operating Income | 1,757 | 2,534 | 3,095 | 2,154 | — | — | — | — | — | |
| Interest Expense | 1,816 | 440 | 1,887 | 1,401 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 1,025 | -1,287 | 0 | 0 | — | — | — | — | — | |
| Net Income Before Taxes | 966 | 806 | 1,209 | 753 | — | — | — | — | — | |
| Income Taxes | 438 | 88 | 267 | 122 | — | — | — | — | — | |
| Consolidated Net Income | 503 | 681 | 932 | 622 | — | — | — | — | — | |
| Net Income From Continuing Operations | 529 | 718 | 941 | 631 | — | — | — | — | — | |
| Net Income | 503 | 681 | 932 | 622 | — | — | — | — | — | |
| EPS (Recurring) | 0.64 | 1.05 | 1.69 | 1.11 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.64 | 1.05 | 1.69 | 1.11 | — | — | — | — | — | |
| EPS (Diluted) | 0.63 | 1.04 | 1.67 | 1.10 | — | — | — | — | — | |
| EBITDA | 2,097 | 1,354 | 3,220 | 2,182 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 15.00 | 10.48 | 6.49 | 9.71 | — | — | — | — | — | |
| Price To Sales Ratio | 0.87 | 1.08 | 1.13 | 1.37 | — | — | — | — | — | |
| Gross Margin | 82.83 | 90.49 | 94.39 | 95.32 | — | — | — | — | — | |
| Operating Margin | 28.89 | 44.57 | 65.31 | 57.33 | — | — | — | — | — | |
| Net Margin | 8.27 | 11.98 | 19.67 | 16.56 | — | — | — | — | — | |
| Shares Outstanding | 558 | 565 | 495 | 482 | — | — | — | — | — | |
| Market Capitalization | 5,273 | 6,159 | 5,361 | 5,148 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Hebard Peggy Hwan | Director | Aug 20 '26 | Sale | 10.18 | 14,520 | 147,741 | 82,259 | Aug 25 |
| Saltzman David | Director | May 20 '26 | Sale | 9.25 | 80,922 | 748,345 | 44,248 | May 22 |
| Zeiden David | Chief Legal Officer | Feb 27 '26 | Option Exercise | 0.00 | 9,217 | 0 | 9,217 | Mar 03 |
| Zeiden David | Chief Legal Officer | Feb 27 '26 | Sale | 10.11 | 9,217 | 93,156 | 0 | Mar 03 |
| Zeiden David | Chief Legal Officer | Nov 14 '25 | Option Exercise | 0.00 | 19,285 | 0 | 19,285 | Nov 18 |
| Zeiden David | Chief Legal Officer | Nov 14 '25 | Sale | 11.11 | 19,285 | 214,160 | 0 | Nov 18 |
| Nierenberg Michael | Chief Executive Officer | Nov 05 '25 | Sale | 11.00 | 301,548 | 3,316,093 | 0 | Nov 06 |
| MCGINNIS ROBERT | Director | Nov 23 '21 | Buy | 25.18 | 4,000 | 100,726 | 4,000 | Nov 23 |
| Nierenberg Michael | Chairman, CEO & President | Apr 19 '21 | Buy | 10.10 | 100,000 | 1,010,000 | 357,028 | Apr 19 |
| Tyson Alan L. | Director | Jul 27 '20 | Buy | 7.72 | 10,000 | 77,184 | 149,158 | Jul 28 |
| Sloves Andrew | Director | May 29 '20 | Buy | 7.29 | 3,600 | 26,253 | 3,700 | Jun 02 |
| LENEHAN PAMELA F | Director | Mar 19 '20 | Buy | 5.53 | 10,000 | 55,310 | 18,865 | Mar 20 |
| Sloves Andrew | Director | Mar 19 '20 | Buy | 6.03 | 10,000 | 60,273 | 62,743 | Mar 19 |
| Sloves Andrew | Director | Mar 18 '20 | Buy | 6.30 | 11,000 | 69,300 | 52,743 | Mar 19 |
| Tyson Alan L. | Director | Mar 18 '20 | Buy | 5.01 | 10,000 | 50,100 | 125,735 | Mar 18 |